Cardiac troponin assays: A review of quantitative point-of-care devices and their efficacy in the diagnosis of myocardial infarction

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 5, 2015, Pages 665-676

  Amundson, Beret E ^b,c   Apple, Fred S ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b ST OLAF COLLEGE   (United States)

^c NONE   (United States)

Author keywords

cardiac troponin; immunoassay; point of care

Indexed keywords

TROPONIN I; TROPONIN T; TROPONIN;

CARDIOVASCULAR DIAGNOSTIC DEVICE; DEVICE COMPARISON; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEART INFARCTION; HEART MUSCLE NECROSIS; HOSPITAL COST; HUMAN; MEASUREMENT ACCURACY; POINT OF CARE TESTING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; CLINICAL CHEMISTRY; DEVICE APPROVAL; DEVICES; HEART MUSCLE; METABOLISM; MYOCARDIAL INFARCTION;

CLINICAL CHEMISTRY TESTS; DEVICE APPROVAL; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; POINT-OF-CARE TESTING; TROPONIN;

EID: 84928008673     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0837     Document Type: Review

References (33)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics - 2014 update. Circulation 2014;129:399-410.
2. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
3. McDonnell B, Hearty S, Leonard P, O'Kennedy R. Cardiac biomarkers and the case for point-of-care testing. Clin Biochem 2009;42:549-61.
4. Kemp M, Donovan J, Higham H, Hooper J. Biochemical markers of myocardial injury. Br J Anaesth 2004;93:63-73.
5. Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol 2011;58:1819-24.
6. Love S, Apple FS. Cardiac troponin serial ordering recommendations: for today and tomorrow. Clin Lab News 2014;40:8-10.
7. Thygeson K, Alpert JS, Jaffe A, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98.
8. Christenson RH, Azzazy HM. Cardiac point of care testing: a focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms. Clin Biochem 2008;42:150-7.
9. Yang Z, Zhou DM. Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction. Clin Biochem 2006;8:771-80.
10. Kalorama Information. The world market for point of care (POC) diagnostics. Available from: http://www.kaloramainformation. com/Point-Care-Diagnostics-7174621/. Accessed on 2 July, 2014.
11. Nichols, JH, editor. Laboratory medicine practice guidelines: evidence based practice for point-of-care testing [monograph on the internet]. Washington DC: AACC press, 2006. Available from: http://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/POCT/POCT%20Entire%20LMPG.pdf. Accessed 18 July, 2014.
12. Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012;33:2252-7.
13. Wu AH, Jaffe A. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2007;155:208-14.
14. Jaffe A, Apple FS, Morrow DA, Lindahl B, Katus, H. Being rational about (im)precision: a statement from the biochemistry subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction. Clin Chem 2010;56:941-3.
15. Thygeson K, Alpert JS, Jaffe A, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Circulation 2012;126:2020-35.
16. Azzazy H, Christenson, RH. Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing? Clin Biochem 2002;35:13-27.
17. Palamalai V, Murakami MM, Apple FS. Diagnostic performance of four point of care troponin I assays to rule in and rule out acute myocardial infarction. Clin Biochem 2013;46:1631-5.
18. Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med 2006;44:750-9.
19. Triage Cardiac Panel [package insert]. San Diego, CA: Alere San Diego, Inc., 2014.
20. Radiometer. AQT90 FLEX analyzer. Available from: http://www.radiometer.com/en/products/immunoassay/aqt90-flex-analyzer. Accessed on 12 June, 2014.
21. AQT90 FLEX TnI Test Kit [package insert]. Brønshøj, Denmark: Radiometer, 2011.
22. AQT90 FLEX TnT Test Kit [package insert]. Brønshøj, Denmark: Radiometer, 2010.
23. i-STAT cardiac troponin I (cTnI) [package insert]. Abbott Park, IL: Abbott Point of Care Inc., 2013.
24. Meritas POC analyzer. Meritas-a new era in point-of-care diagnostics. Available from: http://www.meritaspoc.com. Accessed on 12 June, 2014.
25. Meritas Troponin I [package insert]. Co Wicklow, Ireland: Trinity Biotech, 2013.
26. PATHFAST cTnI-II [package insert]. Tokyo, Japan: Mitsubishi Chemical Medience Corporation, 2011.
27. RAMP Troponin I Assay [package insert]. Vancouver, BC Canada: Response Biomedical Corporation.
28. Stratus CS STAT Fluorometric Analyzer [package insert]. Newark, DE: Siemens Healthcare Diagnostics Inc., 2008.
29. Siemens. Stratus CS acute care diagnostic system. Available from: http://www.healthcare.siemens.com/point-of-care/cardiac/stratus-cs-acute-care. Accessed on 2 July, 2014.
30. VIDAS Troponin I Ultra [package insert]. Durham, NC: bioMérieux, Inc., 2007.
31. Roche. Investor Update. Available from: http://www.roche.com/investors/ir-update/inv-update-2007-02-16.htm19. Accessed on 16 July, 2014.
32. Roche CARDIAC T Quantitative cobas [package insert]. Mannheim, Germany: Roche Diagnostics, 2011.
33. Sieck S. The evolution of a new standard of hospital care: paradigm shift to the emergency department and the role of point-of-care testing. Point of Care 2006;5:2-5.